The present stock price for Boston Scientific Corp (BSX) is $104.26. In the last trading session, the stock made a considerable jump, reaching $140.0 after an opening price of $104.34. The stock briefly fell to $99.0 before ending the session at $104.83.
Boston Scientific Corp saw a rather consistency, in terms of market performance.
52-week price history of BSX Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Boston Scientific Corp’s current trading price is -4.30% away from its 52-week high, while its distance from the 52-week low is 42.78%. The stock’s price range during this period has spanned from $73.02 to $108.94. In the Healthcare sector, the Boston Scientific Corp’s shares surpassed a trading volume of approximately 3.77 million for the day, which was noticeably lower compared to the average daily volume of 9.7.38 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Boston Scientific Corp (BSX) has experienced a quarterly rise of 0.13% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 154.49B and boasts a workforce of 53000 employees.
A Closer Look at Analysts’ Ratings for Boston Scientific Corp
As of right now, 24 analysts are rating Boston Scientific Corp as a BUY, 6 of the polled analysts branded the stock as an OVERWEIGHT, 3 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 102.01, with a change in price of +8.55. Similarly, Boston Scientific Corp recorded 7,856,425 in trading volume during the last 100 days, posting a change of +8.97%.
Examining BSX’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for BSX stands at 0.54. Similarly, the long-term debt-to-equity ratio is also 0.52.
BSX Stock Stochastic Average
Today, Boston Scientific Corp’s raw stochastic average for the past 50 days stands at 54.11%, indicating a rise from the raw stochastic average of the last 20 days, which was 31.61%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 48.83% and 53.56% respectively.
BSX Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price gain of 39.95% this year. Over the last six months, there has been a weaker performance of 0.70%. The price of BSX fallen by 1.81% during the last 30 days period. For the last 5-days stocks have slided -2.34%.
